Cargando…
Cooling down with Entresto. Can sacubitril/valsartan combination enhance browning more than coldness?
BACKGROUND: It is a growing importance to induce a new treatment approach to encourage weight loss but also to improve maintenance of lost weight. It has been shown that promotion of brown adipose tissue (BAT) function or acquisition of BAT characteristics in white adipose tissue (terms referred as...
Autores principales: | Nikolic, Marina, Novakovic, Jovana, Ramenskaya, Galina, Kokorekin, Vladimir, Jeremic, Nevena, Jakovljevic, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686067/ https://www.ncbi.nlm.nih.gov/pubmed/36419097 http://dx.doi.org/10.1186/s13098-022-00944-4 |
Ejemplares similares
-
Exploring the Food and Drug Administration’s review and approval of Entresto (sacubitril/valsartan)
por: Eadie, Ashley L., et al.
Publicado: (2021) -
Rhabdomyolysis After Coadministration of Atorvastatin and Sacubitril/Valsartan (Entresto™) in a 63-Year-Old Woman
por: Faber, Eve S., et al.
Publicado: (2016) -
Sacubitril‐valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO‐SAS study
por: Jaffuel, Dany, et al.
Publicado: (2021) -
Impact of sacubitril–valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO‐SAS study design
por: Jaffuel, Dany, et al.
Publicado: (2018) -
Cardioplegia in Open Heart Surgery: Age Matters
por: Bradić, Jovana, et al.
Publicado: (2023)